Catalyst Crew Technologies Expands into Venezuela to Advance Digital Health and AI Healthcare Solutions

Catalyst Crew Technologies Corp., a digital health and artificial intelligence technology company, has established an operating presence in Venezuela as part of its broader strategy to expand healthcare technology initiatives in Latin America. The company formed a wholly owned operating subsidiary in Venezuela to support local operations, infrastructure development, and the planned deployment of its digital health and artificial intelligence platforms. This local entity is intended to facilitate the company's ability to evaluate market opportunities, develop strategic partnerships, and support the implementation of healthcare technology solutions, including telehealth services, remote patient monitoring, and artificial intelligence-enabled healthcare analytics platforms.

Management believes that establishing an operating presence in Venezuela represents an important step in the company's regional strategy, providing a foundation for potential pilot programs, service deployment, and collaboration with healthcare providers and organizations within the country. The company's artificial intelligence healthcare platform, including modular systems such as CardioAI, PulmoAI, and NeuroAI, is intended to be integrated into its broader healthcare services infrastructure as development progresses. Catalyst Crew Technologies intends to prioritize market development in Latin America, where the company believes technology-enabled healthcare solutions may help expand access to medical services, improve diagnostic capabilities, and support more efficient healthcare delivery.

Dr. Kevin Rodan Levy, Chief Executive Officer of Catalyst Crew Technologies Corp., stated that establishing a local operating presence is an important step in executing the regional strategy. The company believes that combining artificial intelligence-driven healthcare technologies with localized healthcare infrastructure can support more accessible and efficient delivery of medical services. The company intends to continue evaluating opportunities to expand its presence in Latin America while advancing its digital health and artificial intelligence platform initiatives. For more information, investors can review the company's filings with the U.S. Securities and Exchange Commission at https://www.sec.gov or visit the company website at https://catalystcrewai.com.

The expansion into Venezuela matters because it represents a strategic move to address healthcare accessibility challenges in emerging markets through technology. By deploying AI platforms like CardioAI, PulmoAI, and NeuroAI, the company aims to enhance diagnostic accuracy and remote care capabilities in regions with limited medical infrastructure. This initiative could potentially transform healthcare delivery in Latin America by making specialized medical services more available through digital channels. The establishment of a local subsidiary enables deeper market integration and partnership development with Venezuelan healthcare providers, which is crucial for adapting technology to local needs and regulatory environments.

The implications of this announcement extend beyond immediate business expansion to potential improvements in public health outcomes. If successfully implemented, these AI-driven solutions could help address physician shortages, reduce healthcare costs, and improve patient monitoring in underserved areas. The move also signals growing corporate interest in Venezuela's developing technology sector despite economic challenges. However, the company acknowledges in its forward-looking statements that actual results may differ materially from expectations due to various factors including regulatory requirements, market conditions, and implementation challenges. The success of this initiative will depend on the company's ability to navigate local healthcare systems, secure necessary approvals, and demonstrate the practical value of its technologies in improving patient care.